429 related articles for article (PubMed ID: 15540161)
21. A novel Wilms tumor 1 (WT1) target gene negatively regulates the WNT signaling pathway.
Kim MS; Yoon SK; Bollig F; Kitagaki J; Hur W; Whye NJ; Wu YP; Rivera MN; Park JY; Kim HS; Malik K; Bell DW; Englert C; Perantoni AO; Lee SB
J Biol Chem; 2010 May; 285(19):14585-93. PubMed ID: 20220130
[TBL] [Abstract][Full Text] [Related]
22. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of the Wilms' tumor gene WT1 in human bone and soft-tissue sarcomas.
Ueda T; Oji Y; Naka N; Nakano Y; Takahashi E; Koga S; Asada M; Ikeba A; Nakatsuka S; Abeno S; Hosen N; Tomita Y; Aozasa K; Tamai N; Myoui A; Yoshikawa H; Sugiyama H
Cancer Sci; 2003 Mar; 94(3):271-6. PubMed ID: 12824921
[TBL] [Abstract][Full Text] [Related]
24. Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells.
Vidovic K; Svensson E; Nilsson B; Thuresson B; Olofsson T; Lennartsson A; Gullberg U
Leukemia; 2010 May; 24(5):992-1000. PubMed ID: 20237505
[TBL] [Abstract][Full Text] [Related]
25. Expression and mutation analysis of the Wilms' tumor 1 gene in human neural tumors.
Dennis SL; Manji SS; Carrington DP; Scarcella DL; Ashley DM; Smith PJ; Algar EM
Int J Cancer; 2002 Feb; 97(5):713-5. PubMed ID: 11807803
[TBL] [Abstract][Full Text] [Related]
26. WT1 induces apoptosis through transcriptional regulation of the proapoptotic Bcl-2 family member Bak.
Morrison DJ; English MA; Licht JD
Cancer Res; 2005 Sep; 65(18):8174-82. PubMed ID: 16166292
[TBL] [Abstract][Full Text] [Related]
27. Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis.
Miyoshi Y; Iwao K; Nawa G; Yoshikawa H; Ochi T; Nakamura Y
Oncol Res; 1998; 10(11-12):591-4. PubMed ID: 10367940
[TBL] [Abstract][Full Text] [Related]
28. Possible association between higher beta-catenin mRNA expression and mutated beta-catenin in sporadic desmoid tumors: real-time semiquantitative assay by TaqMan polymerase chain reaction.
Saito T; Oda Y; Kawaguchi K; Tanaka K; Matsuda S; Tamiya S; Iwamoto Y; Tsuneyoshi M
Lab Invest; 2002 Jan; 82(1):97-103. PubMed ID: 11796830
[TBL] [Abstract][Full Text] [Related]
29. Expression of WT1 protein in fetal kidneys and Wilms tumors.
Grubb GR; Yun K; Williams BR; Eccles MR; Reeve AE
Lab Invest; 1994 Oct; 71(4):472-9. PubMed ID: 7967503
[TBL] [Abstract][Full Text] [Related]
30. Desmoplastic fibroma of bone: an immunohistochemical study including beta-catenin expression and mutational analysis for beta-catenin.
Hauben EI; Jundt G; Cleton-Jansen AM; Yavas A; Kroon HM; Van Marck E; Hogendoorn PC
Hum Pathol; 2005 Sep; 36(9):1025-30. PubMed ID: 16153468
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
32. WT1 is a tumor-associated antigen in colon cancer that can be recognized by in vitro stimulated cytotoxic T cells.
Koesters R; Linnebacher M; Coy JF; Germann A; Schwitalle Y; Findeisen P; von Knebel Doeberitz M
Int J Cancer; 2004 Apr; 109(3):385-92. PubMed ID: 14961577
[TBL] [Abstract][Full Text] [Related]
33. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
Scharnhorst V; Menke AL; Attema J; Haneveld JK; Riteco N; van Steenbrugge GJ; van der Eb AJ; Jochemsen AG
Oncogene; 2000 Feb; 19(6):791-800. PubMed ID: 10698497
[TBL] [Abstract][Full Text] [Related]
34. Novel frame shift mutations ('A' deletion) observed in exon 9 of Wilms' tumor (WT1) gene in a patient reported with glomerulosclerosis.
Pasupuleti SK; Katari V; Lokanathan S; Uppu VP; Thummaginjala SS; Akkamgari RP; Ayapati T; Kottu R; Potukuchi VG
Gene; 2014 Aug; 546(1):63-7. PubMed ID: 24853201
[TBL] [Abstract][Full Text] [Related]
35. WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene.
Mayo MW; Wang CY; Drouin SS; Madrid LV; Marshall AF; Reed JC; Weissman BE; Baldwin AS
EMBO J; 1999 Jul; 18(14):3990-4003. PubMed ID: 10406804
[TBL] [Abstract][Full Text] [Related]
36. Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1.
Sim EU; Smith A; Szilagi E; Rae F; Ioannou P; Lindsay MH; Little MH
Oncogene; 2002 May; 21(19):2948-60. PubMed ID: 12082525
[TBL] [Abstract][Full Text] [Related]
37. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Han Y; San-Marina S; Yang L; Khoury H; Minden MD
Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
[TBL] [Abstract][Full Text] [Related]
38. Analysis of Wnt/Beta catenin signalling in desmoid tumors.
Tejpar S; Michils G; Denys H; Van Dam K; Nik SA; Jadidizadeh A; Cassiman JJ
Acta Gastroenterol Belg; 2005; 68(1):5-9. PubMed ID: 15832580
[TBL] [Abstract][Full Text] [Related]
39. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.
Zhang X; Xing G; Saunders GF
Anticancer Res; 1999; 19(3A):1641-8. PubMed ID: 10470095
[TBL] [Abstract][Full Text] [Related]
40. Sequential WT1 and CTNNB1 mutations and alterations of beta-catenin localisation in intralobar nephrogenic rests and associated Wilms tumours: two case studies.
Fukuzawa R; Heathcott RW; More HE; Reeve AE
J Clin Pathol; 2007 Sep; 60(9):1013-6. PubMed ID: 17172473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
